Clinical Laserthermia Systems AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Clinical Laserthermia Systems AB (publ) Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Clinical Laserthermia Systems AB (publ), the average price target is kr53.00, with a high estimate of kr53.00 and a low estimate of kr53.00. That is a potential upside of approximately 223.96% from the last closing price of kr16.36 on May, 2024. If you want to invest in CLS B stock, you might also want to take a look at how its competitors are doing.
223.96% Upside
Clinical Laserthermia Systems AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Clinical Laserthermia Systems AB (publ)'s Price has grown, moving from kr0.00 to kr0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to kr0.00 – up 100.00% from the current level. Looking ahead to six years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GETI B Stock Forecast | Getinge AB | Outperform |
18
|
kr231.90 | Buy/Sell | kr226.10 | -1.68% |
| EKTA B Stock Forecast | Elekta AB (publ) | Hold |
18
|
kr77.00 | Buy/Sell | kr83.00 | 1.30% |
| ALIF B Stock Forecast | AddLife AB (publ) | Buy |
18
|
kr100.00 | Buy/Sell | kr111.00 | 37.00% |
| SUS Stock Forecast | Surgical Science Sweden AB (pu... | Outperform |
14
|
kr155.10 | Buy/Sell | kr230.33 | 45.07% |
| CEVI Stock Forecast | CellaVision AB (publ) | Outperform |
16
|
kr227.50 | Buy/Sell | kr191.75 | 7.69% |
Clinical Laserthermia Systems AB (publ) Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Clinical Laserthermia Systems AB (publ)'s Revenue has grown, moving from kr1.48M to kr9.01M – an increase of 508.78%. According to 0 analysts, Clinical Laserthermia Systems AB (publ)'s Revenue will fall by 42.91% in the next year, reaching kr5.14M. Professionals believe that By 2030, Clinical Laserthermia Systems AB (publ)'s Revenue will fall to kr5.81M – a 35.56% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BICO Stock Forecast | BICO Group AB (publ) | Buy |
7
|
kr47.46 | Buy/Sell | kr135.00 | 179.18% |
| HANDI Stock Forecast | Handicare Group AB (publ) | - |
16
|
kr0.00 | Buy/Sell | kr4.92 | 0.00% |
| CRAD B Stock Forecast | C-Rad AB (publ) | Outperform |
11
|
kr39.15 | Buy/Sell | kr65.50 | 48.15% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SYNT Stock Forecast | SyntheticMR AB (publ) | Outperform |
14
|
kr27.70 | Buy/Sell | kr30.00 | 8.30% |
| MNTC Stock Forecast | Mentice AB (publ) | Outperform |
6
|
kr36.60 | Buy/Sell | kr67.17 | 50.27% |
| SEZI Stock Forecast | Senzime AB (publ) |
6
|
kr7.38 | Buy/Sell | kr13.50 | 82.93% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PAX Stock Forecast | Paxman AB (publ) |
8
|
kr36.50 | Buy/Sell | kr84.00 | 119.18% | |
| SPEC Stock Forecast | SpectraCure AB (publ) | - |
0
|
kr2.80 | Buy/Sell | kr0.00 | -100.00% |
| QLINEA Stock Forecast | Q-linea AB (publ) |
6
|
kr2.56 | Buy/Sell | kr10.00 | 232.03% |
Clinical Laserthermia Systems AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for Clinical Laserthermia Systems AB (publ) has grown by 23.85%, going from kr-51.12M to kr-63.31M. For the following year, the 1 analysts predict that Clinical Laserthermia Systems AB (publ)'s EBITDA will drop by 32.55%, reaching kr-42.70M. In 2030, the professionals' prediction is that CLS B's EBITDA will decrease by 57.62%, reaching kr-26.83M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LUMITO Stock Forecast | Lumito AB (publ) | - |
0
|
kr1.75 | Buy/Sell | kr0.00 | -100.00% |
| ACARIX Stock Forecast | Acarix AB (publ) |
0
|
kr0.26 | Buy/Sell | kr0.65 | 130.77% | |
| MEDF Stock Forecast | Medfield Diagnostics AB (publ) | - |
0
|
kr0.29 | Buy/Sell | kr0.00 | -100.00% |
Clinical Laserthermia Systems AB (publ) EBIT Forecast for 2023 - 2025 - 2030
Clinical Laserthermia Systems AB (publ)'s EBIT has grown in the last three years, jumping from kr-51.81M to kr-65.93M – an increase of 27.25%. In the following year, the 1 analysts surveyed believe that Clinical Laserthermia Systems AB (publ)'s EBIT will decrease by 31.29%, reaching kr-45.30M. For the next seven years, the forecast is for EBIT to grow by 17028.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OM:IRRAS Stock Forecast | IRRAS AB (publ) |
0
|
kr0.16 | Buy/Sell | kr2.58 | 3025.00% | |
| CMH Stock Forecast | Chordate Medical Holding AB (p... | - |
0
|
kr0.10 | Buy/Sell | kr0.00 | -100.00% |
| ARCOMA Stock Forecast | Arcoma AB |
0
|
kr13.30 | Buy/Sell | kr12.50 | 12.78% |
Clinical Laserthermia Systems AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Clinical Laserthermia Systems AB (publ)'s EPS has grown, moving from kr-0.85 to kr0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to kr0.00 – up 100.00% from the current level. Looking ahead to six years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| REDS Stock Forecast | Redsense Medical AB (publ) | - |
-10
|
kr5.46 | Buy/Sell | kr0.00 | -100.00% |
| RNBS Stock Forecast | RNB Retail and Brands AB (publ... | - |
0
|
kr49.00 | Buy/Sell | kr250.00 | -100.00% |
| HEART Stock Forecast | Scandinavian Real Heart AB (Pu... | - |
0
|
kr0.57 | Buy/Sell | kr0.00 | -100.00% |
Site Navigation
.jpg)